{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:16:33Z","timestamp":1793146593318,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005610","name":"Fukuoka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ejphar.2019.172738","type":"journal-article","created":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T10:30:17Z","timestamp":1570876217000},"page":"172738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["High expression of NAMPT in adult T-cell leukemia\/lymphoma and anti-tumor activity of a NAMPT inhibitor"],"prefix":"10.1016","volume":"865","author":[{"given":"Tomohiro","family":"Kozako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Ohsugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ichiro","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naho","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172738_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.exphem.2003.11.008","article-title":"HTLV-I Tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an anti-oxidant, in adult T cell leukemia cells","volume":"32","author":"Arima","year":"2004","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ejphar.2019.172738_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/cbt.10.2.12581","article-title":"Nampt\/PBEF\/visfatin and cancer","volume":"10","author":"Bi","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejphar.2019.172738_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4161\/auto.5635","article-title":"NAD depletion by FK866 induces autophagy","volume":"4","author":"Billington","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2019.172738_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrm1616","article-title":"Calorie restriction, SIRT1 and metabolism: understanding longevity","volume":"6","author":"Bordone","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2019.172738_bib5","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1182\/blood-2012-03-416776","article-title":"Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1\/2) inhibition","volume":"120","author":"Cea","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2019.172738_bib6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4161\/auto.21028","article-title":"A novel image-based cytometry method for autophagy detection in living cells","volume":"8","author":"Chan","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2019.172738_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/acsmedchemlett.7b00414","article-title":"Dual NAMPT\/HDAC inhibitors as a new strategy for multitargeting antitumor drug discovery","volume":"9","author":"Chen","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2019.172738_bib8","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1124\/pr.112.007120","article-title":"Therapeutic targeting of autophagy in disease: biology and pharmacology","volume":"65","author":"Cheng","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2019.172738_bib9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ceb.2004.09.008","article-title":"Life's smile, death's grin: vital functions of apoptosis-executing proteins","volume":"16","author":"Garrido","year":"2004","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejphar.2019.172738_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tem.2008.10.004","article-title":"Nampt: linking NAD biology, metabolism and cancer","volume":"20","author":"Garten","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172738_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4161\/auto.27722","article-title":"A critical role of autophagy in antileukemia\/lymphoma effects of APO866, an inhibitor of NAD biosynthesis","volume":"10","author":"Ginet","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2019.172738_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.tcb.2011.03.007","article-title":"Autophagy and apoptosis: what is the connection?","volume":"21","author":"Gump","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejphar.2019.172738_bib13","first-page":"7436","article-title":"FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis","volume":"63","author":"Hasmann","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172738_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12325-018-0658-4","article-title":"A review of new findings in adult T-cell leukemia-lymphoma: a focus on current and emerging treatment strategies","volume":"35","author":"Hermine","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejphar.2019.172738_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10637-007-9083-2","article-title":"The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor","volume":"26","author":"Holen","year":"2008","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.ejphar.2019.172738_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12013-008-9041-4","article-title":"The NAD World: a new systemic regulatory network for metabolism and aging--Sirt1, systemic NAD biosynthesis, and their importance","volume":"53","author":"Imai","year":"2009","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2019.172738_bib17","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/npjsba.2016.18","article-title":"The NAD World 2.0: the importance of the inter-tissue communication mediated by NAMPT\/NAD+\/SIRT1 in mammalian aging and longevity control","volume":"2","author":"Imai","year":"2016","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.ejphar.2019.172738_bib18","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejphar.2019.172738_bib19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1021\/acsmedchemlett.8b00254","article-title":"Nicotinamide phosphoribosyltransferase inhibitor as a novel payload for antibody-drug conjugates","volume":"9","author":"Karpov","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2019.172738_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3960\/jslrt.17008","article-title":"Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma","volume":"57","author":"Katsuya","year":"2017","journal-title":"J. Clin. Exp. Hematop."},{"key":"10.1016\/j.ejphar.2019.172738_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2019.172738_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172738_bib23","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/cas.13303","article-title":"Genetic alterations in adult T-cell leukemia\/lymphoma","volume":"108","author":"Kogure","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejphar.2019.172738_bib24","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/ijc.27481","article-title":"High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells","volume":"131","author":"Kozako","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.172738_bib25","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.4049\/jimmunol.177.8.5718","article-title":"Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients","volume":"177","author":"Kozako","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2019.172738_bib26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1186\/s12885-018-4710-1","article-title":"Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines","volume":"18","author":"Kozako","year":"2018","journal-title":"BMC Canc."},{"key":"10.1016\/j.ejphar.2019.172738_bib27","doi-asserted-by":"crossref","first-page":"27645","DOI":"10.18632\/oncotarget.25291","article-title":"The small molecule STF-62247 induces apoptotic and autophagic cell death in leukemic cells","volume":"9","author":"Kozako","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.172738_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/2211-5463.12055","article-title":"Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T-cell leukemia cells","volume":"6","author":"Kozako","year":"2016","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ejphar.2019.172738_bib29","doi-asserted-by":"crossref","first-page":"20295","DOI":"10.3390\/molecules191220295","article-title":"Anticancer agents targeted to sirtuins","volume":"19","author":"Kozako","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2019.172738_bib30","doi-asserted-by":"crossref","first-page":"11345","DOI":"10.1038\/srep11345","article-title":"Novel small-molecule SIRT1 inhibitors induce cell death in adult T-cell leukaemia cells","volume":"5","author":"Kozako","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2019.172738_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/leu.2008.272","article-title":"PD-1\/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia\/lymphoma patients","volume":"23","author":"Kozako","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.ejphar.2019.172738_bib32","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1158\/1078-0432.CCR-17-2575","article-title":"NAMPT is a potent oncogene in colon cancer progression that modulates cancer stem cell properties and resistance to therapy through Sirt1 and PARP","volume":"24","author":"Lucena-Cacace","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172738_bib33","doi-asserted-by":"crossref","first-page":"99514","DOI":"10.18632\/oncotarget.20577","article-title":"NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis","volume":"8","author":"Lucena-Cacace","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.172738_bib34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2019.172738_bib35","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/294770a0","article-title":"Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells","volume":"294","author":"Miyoshi","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172738_bib36","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1158\/1078-0432.CCR-04-1399","article-title":"Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy","volume":"11","author":"Muruganandham","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172738_bib37","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1182\/blood-2008-08-173369","article-title":"The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies","volume":"113","author":"Nahimana","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2019.172738_bib38","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/carcin\/bgi095","article-title":"In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia","volume":"26","author":"Ohsugi","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2019.172738_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.canlet.2007.07.017","article-title":"Dehydroxymethylepoxyquinomicin (DHMEQ) therapy reduces tumor formation in mice inoculated with tax-deficient adult T-cell leukemia-derived cell lines","volume":"257","author":"Ohsugi","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2019.172738_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/cr.2013.169","article-title":"Historical landmarks of autophagy research","volume":"24","author":"Ohsumi","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.ejphar.2019.172738_bib41","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1158\/1535-7163.MCT-09-1130","article-title":"A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor","volume":"9","author":"Olesen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejphar.2019.172738_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cyto.a.10074","article-title":"Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: a caution in data interpretation","volume":"55","author":"Pozarowski","year":"2003","journal-title":"Cytometry"},{"key":"10.1016\/j.ejphar.2019.172738_bib43","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cellsig.2016.03.009","article-title":"AMPK\/Snf1 signaling regulates histone acetylation: impact on gene expression and epigenetic functions","volume":"28","author":"Salminen","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2019.172738_bib44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pharmthera.2015.02.004","article-title":"Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer","volume":"151","author":"Sampath","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2019.172738_bib45","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1038\/s41598-019-39424-7","article-title":"Degradation of p47 by autophagy contributes to CADM1 overexpression in ATLL cells through the activation of NF-kappaB","volume":"9","author":"Sarkar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2019.172738_bib46","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172738_bib47","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.3390\/ijms15023145","article-title":"Autophagic cell death and cancer","volume":"15","author":"Shimizu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2019.172738_bib48","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2019.172738_bib49","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/leu.2013.264","article-title":"Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy","volume":"28","author":"Stankov","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ejphar.2019.172738_bib50","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1038\/onc.2008.311","article-title":"Caspase-independent cell death: leaving the set without the final cut","volume":"27","author":"Tait","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2019.172738_bib51","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1074\/jbc.M112.394510","article-title":"Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications","volume":"288","author":"Tan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172738_bib52","first-page":"101754","article-title":"Clinical trials and treatment of ATL","volume":"2012","author":"Tsukasaki","year":"2012","journal-title":"Leuk. Res. Treat."},{"key":"10.1016\/j.ejphar.2019.172738_bib53","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2019.172738_bib54","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00280-009-1125-3","article-title":"Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data","volume":"65","author":"von Heideman","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172738_bib55","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3892\/or.2015.4146","article-title":"The novel mTOR inhibitor Torin-2 induces autophagy and downregulates the expression of UHRF1 to suppress hepatocarcinoma cell growth","volume":"34","author":"Wang","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2019.172738_bib56","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.febslet.2010.01.009","article-title":"Autophagy in cellular growth control","volume":"584","author":"Wang","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2019.172738_bib57","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/1535-7163.MCT-16-0819","article-title":"Discovery and characterization of novel nonsubstrate and substrate NAMPT inhibitors","volume":"16","author":"Wilsbacher","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejphar.2019.172738_bib58","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","article-title":"Multiple viral strategies of HTLV-1 for dysregulation of cell growth control","volume":"19","author":"Yoshida","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2019.172738_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091865","article-title":"Monitoring and measuring autophagy","volume":"18","author":"Yoshii","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2019.172738_bib60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-642-38965-8_12","article-title":"Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia\/lymphoma","volume":"193","author":"Yoshimitsu","year":"2014","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172738_bib61","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2011.11.017","article-title":"Anti-proliferation effect of APO866 on C6 glioblastoma cells by inhibiting nicotinamide phosphoribosyltransferase","volume":"674","author":"Zhang","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172738_bib62","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1158\/1535-7163.MCT-16-0674","article-title":"Discovery of a highly selective NAMPT inhibitor that demonstrates robust efficacy and improved retinal toxicity with nicotinic acid coadministration","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejphar.2019.172738_bib63","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1186\/s12885-015-1845-1","article-title":"EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition","volume":"15","author":"Zucal","year":"2015","journal-title":"BMC Canc."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919306909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919306909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:31:14Z","timestamp":1757975474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919306909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":63,"alternative-id":["S0014299919306909"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172738","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High expression of NAMPT in adult T-cell leukemia\/lymphoma and anti-tumor activity of a NAMPT inhibitor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"172738"}}